ArticleBone reports2026
Are required pre-treatment dental evaluations in the osteoporosis population a barrier to antiresorptive therapies?
Article in Bone reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Dental evaluation is recommended before bisphosphonates (BPs) initiation because of the rare but serious risk of medication-related osteonecrosis of the jaw. In this context, the objective of this study was to assess the prevalence of the indication for dental care (DC) prior to BPs initiation for osteoporosis (OP). Methods: Monocentric retrospective study between January 2019 and August 2022. Inclusion criteria: patients requiring OP treatment with dental evaluation (panoramic dental X-ray (PD) and dental teleconsultation). Exclusion criteria: PD without tele-dental evaluation, BPs for other indications than OP, OP not treated with BPs. Collected data: demographic characteristics, medical history, bone status, conclusions of tele-dental expertise. Results: 130 patients were included, mean age of 74.3 years (±12.2), 102 were women. DC was required for 95/130 patients (DC group). In the DC group, 77/95 required surgical DC, 35/77 completed the surgical DC, and 30/35 initiated BPs. 18/95 patients required non-surgical DC, 6/18 completed the DC, and 5/6 initiated BPs. BPs were initiated in 35/95 (36,8%) patients in the DC group and 29/35 (82,9%) in the non-DC group. Conclusion: The prevalence of DC required before BPs initiation in OP patients is high and have a negative impact on the effective implementation of OP treatment. These results emphasize the need for healthcare policies aimed at improving access to DC and the necessity for clear guidelines regarding DC management in the context of BPs therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.